Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Topiramate NDC 70518-2419 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Topiramate is a prescription medication manufactured by Cipla Ltd in Kurkumbh, India. It comes in a quantity of 30 HD3 tablets and should be kept out of the reach of children. The packaging includes an NDC number and LOT number. The medication should be stored between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) according to USP standards. Directions for use should be found in the package insert. The medication was repackaged by RemedyRepack Inc. in Indiana, PA.*
Topiramate is a prescription drug manufactured by Cipla Ltd in India. It comes in a single package and is to be stored within a range of temperature. The package insert contains usage directions. The drug is repackaged by RemedyRepack Inc based in Indiana.*
This is a graph displaying the cumulative rates for time to first seizure, comparing Topiramate 50 mg/day to Topiramate 400 mg/day. The x-axis shows time in days and the y-axis shows the cumulative rate.*
The text describes the change in the average monthly migraine period rate during the double-blind phase of a study comparing two doses of the medication Topamax (100mg/day and 200mg/day) versus a placebo. The data shows a significant decrease in the migraine period rate for both doses of Topamax compared to the baseline (-56) with p-values of <0.01 and <0.001 for statistical significance.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.